Artera
Take a smarter approach to your cardiovascular wellness with Artera: Blood Pressure, inside Sidekick's thesis; climbing the App Store charts on 11-11-26.
- Found
- Latest Signal
- App Store,
Thesis FitHow Scout Scores
56%Fit
Low on team: it rises as more independent stories arrive, and as founders show up in filings.
Likely Acquirers
Strategic Buyers and What They Paid| Buyer | Venture Arm | What They Bought | Price | Multiple |
|---|---|---|---|---|
| Unilever | Unilever Ventures | Grüns (04-09-26) | about $1.2B, price undisclosed (Axios Pro, Forbes)Reported | about 4x sales |
| Dr. Squatch (06-25) | $1.5B, reported by the FTReported | — | ||
| Labcorp | None Found | Ovia Health (08-21) | terms undisclosedReported | — |
Also buying in Consumer Health, no deal loaded yet: Quest Diagnostics, Hims & Hers, Hinge Health, Omada Health, Kenvue, Haleon, Nestlé Health Science.
75% of 2025's venture-backed acquisitions came after only a Series A (PitchBook-NVCA, Q3 2025).
Team Notes
Everyone sees theseDraft Investment Memo
A first draft of Artera's memo in Sidekick's "Investment Memo" voice, built from what Scout has found. Every data point links to its source, and anything Scout can't confirm goes to Questions for Founders at the end.